Genticel
針對人類乳頭瘤病毒(HPV)感染者研發創新性疫苗的生物制藥公司
GENTICEL is a clinical stage biopharmaceutical company based in Paris and Toulouse, France, which develops vaccines for patients infected with Human Papillomavirus (HPV). Besides ProCervix, its other pipeline products include CyaA-based multivalent HPV vaccines with additional virus subtype coverage.